Evidence map›Paper›PMID 35937656›Full record

ArticleCentral European journal of urology2022

Robotic-assisted, laparoscopic, and open radical cystectomy: surgical data of 1400 patients from The Italian Radical Cystectomy Registry on intraoperative outcomes.

Angelo Porreca, Luca Di Gianfrancesco, Walter Artibani, Gian Maria Busetto, Giuseppe Carrieri, Alessandro Antonelli, Lorenzo Bianchi, Eugenio Brunocilla, Aldo Massimo Bocciardi, Marco Carini and 11 more

Open access · greenAbstract read
In one paragraph

Article in Central European journal of urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Robot-assisted radical cystectomy: Where we are in 2023.Investigative and clinical urology · 2023
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 11 institutions in 1 country.

Angelo PorrecaOncological Urology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
Luca Di GianfrancescoOncological Urology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
Walter ArtibaniDepartment of Urology, Policlinico Abano Terme, Abano Terme, Italy.
Gian Maria BusettoUrology and Renal Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Giuseppe CarrieriUrology and Renal Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Alessandro AntonelliDepartment of Urology, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
Lorenzo BianchiDepartment of Urology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Eugenio BrunocillaDepartment of Urology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Aldo Massimo BocciardiStruttura Complessa Urologia, ASST, Grande Ospedale Metropolitano Niguarda, Milano, Italy.
Marco CariniUnit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Firenze, Italy.
Antonio CeliaDepartment of Urology, San Bassiano Hospital, Bassano Del Grappa, Italy.
Giovanni CochettiDepartment of Urology, University of Perugia, Perugia, Italy.
Andrea GallinaDepartment of Urology and Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute, URI, Urological Research Institute, Milano, Italy.
Ettore MeariniDepartment of Urology, University of Perugia, Perugia, Italy.
Andrea MinerviniDepartment of Urology, Careggi Hospital, University of Florence, Firenze, Italy.
Riccardo SchiavinaDepartment of Urology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Sergio SerniUnit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Firenze, Italy.
Daniele D'AgostinoDepartment of Urology, Ospedale Villa Salus, Mestre, Italy.
Erica DebbiOncological Urology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
Paolo CorsiOncological Urology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
Alessandro CrestaniOncological Urology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
Istituto Oncologico Veneto · ITAzienda USL di Bologna · ITAzienda Ospedaliero-Universitaria Careggi · ITUniversity of Foggia · ITUniversity of Perugia · ITAzienda Ospedaliera Universitaria Integrata Verona · ITAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITIstituto di Ricovero e Cura a Carattere Scientifico San RaffaeleOspedale San Bassiano · ITPoliclinico Abano Terme · ITUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The Italian Radical Cystectomy Registry (Registro Italiano Cistectomie - RIC) aimed to analyse outcomes of a multicenter series of patients treated with radical cystectomy (RC) for bladder cancer. Material and methods: An observational, prospective, multicenter, cohort study was performed to collect data from RC and urinary diversion via open (ORC), laparoscopic (LRC), or robotic-assisted (RARC) techniques performed in 28 Italian Urological Departments. The enrolment was planned from January 2017 to June 2020 (goal: 1000 patients), with a total of 1425 patients included. Chi-square and t-tests were used for categorical and continuous variables. All tests were 2-sided, with a significance level set at p <0.05. Results: Overall median operative-time was longer in RARCs (390 minutes, IQR 335-465) than ORCs (250, 217-309) and LRCs (292, 228-350) (p <0.001). Lymph node dissection (LND) was performed more frequently in RARCs (97.1%) and LRCs (93.5%) than ORCs (85.6%) (p <0.001), with extended-LND performed 2-fold more frequently in RARCs (61.6%) (p <0.001). The neobladder rate was significantly higher (more than one-half) in RARCs. The median estimated blood loss (EBL) rate was lower in RARCs (250 ml, 165-400) than LRCs (330, 200-600) and ORCs (400, 250-600) (p <0.001), with intraoperative blood transfusion rates of 11.4%, 21.7% and 35.6%, respectively (p <0.001). The conversion to open rate was slightly higher in RARCs (6.8%) than LRCs (4.3%). Intraoperative complications occurred in 1.3% of cases without statistically significant differences among the approaches. Conclusions: Data from the RIC confirmed the need to collect as much data as possible in a multicenter manner. RARCs proves to be feasible with perioperative complication rates that do not differ from the other approaches.

Indexed as

bladder cancerintraoperative outcomesmulticenter registryradical cystectomyrobotic-assisted

Identifiers

PMID35937656
PMCPMC9326698
OpenAlexW4285188096

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.